MRUS

Merus N.V. - Common Shares (MRUS)

About Merus N.V. - Common Shares (MRUS)

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Details

Daily high

$56.62

Daily low

$55.26

Price at open

$55.38

52 Week High

$62.98

52 Week Low

$33.19

Market cap

4.1B

Dividend yield

0.00%

Volume

310,155

Avg. volume

626,497

P/E ratio

-13.35

Merus N.V. - Common Shares News